ResearcherNew York UniversityNo recent work listed

Deepak Saxena

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5506-5827; OpenAlex author ID A5026084601. Sources: OpenAlex.

Their work

Papers: 2 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. First author DOI 10.1038/s41586-023-06293-0 ↗
The mycobiome-immune axis: The next frontier in pancreatic cancer. First author DOI 10.1016/j.ccell.2022.01.009 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Li · 1 shared paper, 2022 · strength 0.33
- Paper The mycobiome-immune axis: The next frontier in pancreatic cancer. DOI 10.1016/j.ccell.2022.01.009 ↗
Smruti Pushalkar · 1 shared paper, 2023 · strength 0.26
- Paper Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. DOI 10.1038/s41586-023-06293-0 ↗
Fangxi Xu · 1 shared paper, 2023 · strength 0.26
- Paper Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. DOI 10.1038/s41586-023-06293-0 ↗
George Miller · 1 shared paper, 2023 · strength 0.26
- Paper Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer. DOI 10.1038/s41586-023-06293-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.